Company / Shares Outstanding
Cytek Biosciences, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
128.6M
FY2025
5-year range
31.2M / 133.7M
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#65 of 165
Health Care
What the data says
At 128550136.00, Cytek Biosciences, Inc.'s shares outstanding ranks #101 of 165 in the Health Care sector. Shares Outstanding has declined for 3 consecutive years, from 133749663.00 in FY2022 to 128550136.00 in FY2025.
Based on SEC 10-K filings.
128550136.00 in FY2025 with a 5-year CAGR of +31.6%.
Remained stable around 128550136.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- +31.6%
- 10-Year CAGR
- -
Sector benchmark
#101 of 165 in Health CareTop 61% of 165This company 128.6M Sector average 170.0M
▼
-24.4% below sector average
Key checks
Key Insights
- Cytek Biosciences, Inc.'s shares outstanding has declined for 3 consecutive years.
- In FY2025, shares outstanding decreased 0.5% year-over-year.
- Ranks #65 out of 165 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 128.6M | -0.5% |
| FY2024 | 129.2M | -1.2% |
| FY2023 | 130.7M | -2.3% |
| FY2022 | 133.7M | +328.1% |
| FY2021 | 31.2M | -4.2% |
| FY2020 | 32.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026